Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Acq. announced
Coeptis Therapeutics Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
12/14/2022 15-12G Form 15-12G - Securities registration termination [Section 12(g)]:
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
10/28/2022 8-K Quarterly results
09/30/2022 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
09/21/2022 8-K Investor presentation
Docs: "PRESENTTION",
"Coeptis Therapeutics Enters Exclusive License Agreement with University of Pittsburgh for Rights to SNAP-CAR, a “Multi-Antigen” CAR T Technology"
09/21/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
09/19/2022 SC 13G Hutchinson Thomas reports a 6.3% stake in Coeptis Therapeutics, Inc.
09/16/2022 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
09/07/2022 253G2 Form 253G2 -
09/07/2022 8-K Quarterly results
09/07/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/22/2022 8-K Quarterly results
08/22/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
08/02/2022 10-Q Quarterly Report for the period ended June 30, 2022
07/06/2022 8-K Quarterly results
07/06/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
06/14/2022 RW Form RW - Registration Withdrawal Request:
05/23/2022 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
05/17/2022 8-K Quarterly results
05/17/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/12/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/19/2022 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits  Inte...
Docs: "Agreement and Plan of Merger, by and among Bull Horn, Merger Sub and Coeptis",
"Form of Voting Agreement, by and among Bull Horn, Coeptis and certain stockholders of Coeptis",
"Coeptis Therapeutics, Inc. and Bull Horn Holdings Corp. Announce Merger Agreement"
04/12/2022 8-K Entry into a Material Definitive Agreement  Interactive Data
04/05/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/11/2022 10-K Annual Report for the period ended December 31, 2021
02/25/2022 8-K Quarterly results
12/27/2021 8-K Quarterly results
12/06/2021 253G1 Form 253G1 -
12/06/2021 QUALIF Form QUALIF - Notice of Qualification [Regulation A]:
11/18/2021 1-A Form 1-A - Offering Statement [Regulation A]:
11/15/2021 10-Q Quarterly Report for the period ended September 30, 2021
10/12/2021 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
09/30/2021 8-K Termination of a Material Definitive Agreement  Interactive Data
08/27/2021 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy